Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | 0.00% | +10.05% | -81.51% |
May. 14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.51% | 7.42M | |
-23.57% | 7.61B | |
+7.81% | 6.63B | |
+15.67% | 5.53B | |
-15.54% | 4.89B | |
+16.83% | 4.17B | |
-21.75% | 3.99B | |
-23.41% | 2.88B | |
+44.05% | 2.38B | |
+1.36% | 2.08B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Ascendiant Capital Starts Vivos Therapeutics at Buy With $2.50 Price Target